Growth hormone deficiency screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
==Screening== | ==Screening== | ||
''Genetic screening indications:'' | |||
=== ''Genetic screening indications:'' === | |||
* Early onset of growth failure | * Early onset of growth failure | ||
* Positive family history and possible consanguinity | * Positive family history and possible consanguinity | ||
* Height more than 3 sd below the mean | * Height more than 3 sd below the mean | ||
* Extremely low GH response to provocation tests, including GHRH, and very low IGF-I and IGF-binding protein-3 (IGFBP-3) levels | * Extremely low GH response to provocation tests, including GHRH, and very low IGF-I and IGF-binding protein-3 (IGFBP-3) levels | ||
Revision as of 15:42, 18 August 2017
|
Growth hormone deficiency Microchapters |
|
Differentiating Growth hormone deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Growth hormone deficiency screening On the Web |
|
American Roentgen Ray Society Images of Growth hormone deficiency screening |
|
Risk calculators and risk factors for Growth hormone deficiency screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Screening
Genetic screening indications:
- Early onset of growth failure
- Positive family history and possible consanguinity
- Height more than 3 sd below the mean
- Extremely low GH response to provocation tests, including GHRH, and very low IGF-I and IGF-binding protein-3 (IGFBP-3) levels